These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15706476)

  • 21. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
    Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
    Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality of the performance of clinical laboratories].
    Endróczi E
    Orv Hetil; 1996 Jun; 137(23):1251-8. PubMed ID: 8757095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement.
    Citirik M; Haznedaroglu IC; Teberik K; Soykan E; Zilelioglu O
    Br J Ophthalmol; 2009 Oct; 93(10):1382-6. PubMed ID: 19635722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation.
    Meijer P; Haverkate F
    Semin Thromb Hemost; 2006 Jul; 32(5):485-91. PubMed ID: 16862521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [External quality assurance: a significant--and 25-year-old--element of quality management in the medical diagnostic laboratory].
    Halbmayer WM; Legenstein E; Kaiser E
    Wien Klin Wochenschr; 1995; 107(16):500-6. PubMed ID: 7571645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.
    Westgard JO; Westgard SA
    Am J Clin Pathol; 2006 Mar; 125(3):343-54. PubMed ID: 16613337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of coagulation laboratory practice in Thailand: the first step to establish a National External Quality Assessment Scheme (NEQAS) for blood coagulation.
    Tientadakul P; Opartkiattikul N; Wongtiraporn W
    J Med Assoc Thai; 2007 Dec; 90(12):2616-23. PubMed ID: 18386711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achieving and maintaining quality in the laboratory.
    Hertzberg MS; Mammen J; McCraw A; Nair SC; Srivastava A
    Haemophilia; 2006 Jul; 12 Suppl 3():61-7. PubMed ID: 16683998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lebanese External Quality Assessment Scheme for laboratories: was it worth establishing?
    Hallak G
    J Med Liban; 2005; 53(1):9-15. PubMed ID: 16398207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
    Hillarp A; Egberg N; Nordin G; Stigendal L; Fagerberg I; Lindahl TL
    Thromb Haemost; 2004 Feb; 91(2):300-7. PubMed ID: 14961158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
    Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
    Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control and quality assessment of coagulation tests in Japan.
    Matsuno K; Yasushi T
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():99-103. PubMed ID: 12755278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of reduced levels of protein C, free protein S and antithrombin in normal frozen plasma on the interpretation of patients' results.
    Gupta AD; Sharma A
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):51-5. PubMed ID: 22089940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Has compliance with CLIA requirements really improved quality in US clinical laboratories?
    Ehrmeyer SS; Laessig RH
    Clin Chim Acta; 2004 Aug; 346(1):37-43. PubMed ID: 15234634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2007 Apr; 33(3):235-42. PubMed ID: 17427057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombophilia testing in patients with venous thrombosis.
    Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory evaluation of hypercoagulability.
    Khor B; Van Cott EM
    Clin Lab Med; 2009 Jun; 29(2):339-66. PubMed ID: 19665682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ability of three global plasma assays to recognize thrombophilia.
    Andresen MS; Abildgaard U; Liestøl S; Sandset PM; Mowinckel MC; Ødegaard OR; Larsen ML; Diep LM
    Thromb Res; 2004; 113(6):411-7. PubMed ID: 15226097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.